Tim Cameron is an experienced trial lawyer, with additional extensive experience handling antitrust, securities, shareholder derivative, M&A, and product liability claims, as well as regulatory matters. He is among the few litigators to have taken a securities case through trial, having handled three such trials for Vivendi in some of the most significant and complex securities actions in recent history. More recently, Cameron led the trial team that successfully defended the Louis Dreyfus Company and its subsidiary Imperial Sugar against the Department of Justice’s (DOJ) effort to block the sale of that company to U.S. Sugar—a significant win, that was unanimously affirmed on appeal, in a closely watched antitrust case.
Cameron also has deep experience in a wide variety of complex commercial matters, with a focus on complicated cross‑border issues particularly for non-U.S. clients.
Lawdragon Honors
Examples of Cameron’s current and recent cases include:
- Representing Spirit AeroSystems and certain of its officers in putative class action securities litigation alleging defendants made false and misleading statements regarding the company’s quality controls.
- Representing Xcel Energy, a major U.S. electricity and natural gas company with operations in eight states, and its subsidiary, Southwestern Public Service Company, in more than two dozen actions concerning the February 2024 Texas Panhandle wildfires—which included the Smokehouse Creek Fire.
- Representing Louis Dreyfus Company in multiple putative class action antitrust cases that have been coordinated as part of multidistrict litigation (MDL) in Minnesota concerning an alleged conspiracy related to the price of refined sugar in the U.S.
- Representing Stanley Black & Decker and current and former officers in putative class action securities litigation, as well as related consolidated shareholder derivative actions, in Connecticut federal court alleging the company made false and misleading statements concerning its tool manufacturing business.
- Representing Endava and its CEO and CFO in putative class action securities litigation filed in New York federal court alleging Endava made false and misleading statements concerning the strength of its business prior to the release of its 2Q 2024 earnings results, following which the company’s stock price dropped more than 40%.
- Representing Clearwater Analytics as lead counsel in stockholder derivative litigation alleging, inter alia, that the director defendants breached their fiduciary duties by allegedly causing or allowing certain equity owners to sell company stock based on alleged material non‑public information.
- Representing Spirits International in its dispute against the Russian Federation over the ownership of the famous Stolichnaya vodka trademarks.
- Represented defendants in a confidential International Chamber of Commerce (ICC) arbitration involving cross-border claims in excess of $1 billion.
- Represented 260 Twelfth Avenue Holdings, LLC in litigation filed in New York federal court to obtain just compensation for the taking of property through eminent domain by the National Railroad Passenger Corporation (Amtrak) in connection with the Hudson Tunnel Project in New York City, reaching a settlement shortly before a scheduled trial.
- Led post-trial and appellate proceedings before the Fifth Circuit for Louis Dreyfus in an action brought by the Port of Houston Authority alleging Louis Dreyfus breached its agreement for the lease of a grain elevator, railroad system and surrounding infrastructure from the Port Authority. The parties reached a settlement to resolve the action.
- Representation of Epic Games in antitrust litigation against Google, alleging anticompetitive behavior in the distribution of mobile apps and the handling of in‑app payments. Following a multi‑week trial, a jury unanimously ruled in favor of Epic on all counts.
- Represented Amgen in successfully defending against a Federal Trade Commission (FTC) challenge to its $27.8 billion acquisition of Horizon Therapeutics, the largest acquisition in Amgen’s history. Amgen secured a consent order that ended all litigation and cleared the path for the deal to close.
- Represented Micro Focus International (now OpenText) and certain individual defendants in securing a favorable settlement shortly before trial in putative securities class action litigation filed in New York federal court and California state court concerning its $8.8 billion acquisition of certain of Hewlett Packard Enterprise’s software assets.
- Represented Westpac Banking Corporation in a putative class action asserting, inter alia, antitrust, the Racketeer Influenced and Corrupt Organizations Act (RICO) and Commodity Exchange Act claims premised upon alleged manipulation of the Australian Bank Bill Swap Reference Rate (BBSW).
- Represented Westpac Banking Corporation and its CEO in putative class action securities litigation filed in Oregon federal court concerning the reporting of over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre (AUSTRAC), contrary to Australian law.
- Represented DuPont in an antitrust class action lawsuit filed in Maryland federal court alleging that DuPont and various co‑defendants conspired to fix the price of titanium dioxide.
- Represented the Swedish company Folksam ömsesidig livförsäkring and won the dismissal of an action asserting RICO claims premised upon alleged violations of Swedish financial regulations, fraud and money laundering, as well as claims under the Computer Fraud and Abuse Act and New York common law.
- Represented Chemed Corporation and various individual defendants in consolidated shareholder derivative litigation in Delaware federal court arising from alleged improper billing of Medicare and Medicaid. Mr. Cameron obtained the dismissal of that litigation once, without prejudice, and, following repleading, secured final dismissal of the matter with prejudice as to all defendants. He also represented the company in related securities class action litigation, which settled.
- Represented Novartis Pharmaceuticals in a civil enforcement action filed in New York federal court by the U.S. Attorney’s Office for the Southern District of New York alleging violations of the False Claims Act and Anti‑Kickback Statute.
- Represented Colgate‑Palmolive in several product liability lawsuits around the country, including two jury trials in California state court, one of which resulted in a unanimous jury verdict in Colgate-Palmolive’s favor, while the other was settled on favorable terms. Another case in South Carolina state court settled two days into trial.
- Represented Vivendi, S.A. for over a decade in several matters, including (a) securities class action litigation, which culminated in a four‑month jury trial—the first and only so‑called “foreign cubed” case to have gone to trial; (b) a four‑week jury trial over securities and contract claims in a suit brought by Liberty Media relating, in part, to a transaction involving USA Networks; and (c) a two‑day bench trial in a securities fraud case brought by GAMCO Investors—the first public market purchase case in which the presumption of reliance was successfully rebutted at a trial on the merits.
- Represented AWB Limited (now Agrium Asia Pacific Ltd.) and won dismissals at the motion to dismiss stage of five separate actions relating to AWB’s participation in the U.N. Oil for Food Programme in Iraq and involving various claims including antitrust, civil RICO, Foreign Corrupt Practices Act (FCPA) and Alien Tort Statute claims.